Botulinum toxin type A for chronic neurovascular and myofascial facial pain: a comprehensive case report
Abstract
This article reports on a female patient with chronic orofacial pain, followed up for 12 years. She described her pain as throbbing with intermittent pain attacks, and frequently accompanied by symptoms such as photophobia, phonophobia, and nausea. This was associated with myofascial pain of masticatory muscles, which were very painful on palpation. The patient was diagnosed with a complex pain profile that included chronic facial migraine, chronic masticatory myofascial pain, nonspecific neuropathic components, and generalized facial hypersensitivity. Despite the diversity of pharmacologic treatments, clinical benefit was limited and transient, with many medications discontinued due to adverse effects or lack of efficacy. The successful use of botulinum toxin type A (BoNT-A; Dysport) in treating this patient is presented. Planned administration of BoNT-A into anatomically and symptomatically defined trigger zones produced significant and sustained relief of migraine symptoms, followed up for 2 years. However, mild residual myofascial discomfort persisted. BoNT-A administration has the advantage of providing periodic rather than daily prophylactic treatment, the latter utilized by the present conventional method.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.